Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 08, 2026 07:34 ET | Source: Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals Reports Positive Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis Demonstrating Near-Complete Improvement on Biopsy

Eupraxia Pharmaceuticals Reports Positive Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis Demonstrating Near-Complete Improve
January 08, 2026 07:30 ET | Source: AGM Group Holdings Inc.

AGM Group Announces Strategic Memorandum of Understanding with Amber Premium in Building RWA Tokenization Initiatives

Jan 4, 2026: AGM (AGMH) & Amber (AMBR) signed MOU for RWA tokenization. Amber to provide blockchain tech/support; subject to negotiation & regulations.
January 08, 2026 07:30 ET | Source: Acrivon Therapeutics, Inc

Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11

Electronic data capture (EDC) extract from the ongoing ACR-368 registrational-intent Phase 2b monotherapy trial in OncoSignature-positive (BM+) subjects with endometrial cancer (EC) showed 39% overall...
January 08, 2026 07:30 ET | Source: Anavex Life Sciences Corp.

Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology

NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative...
January 08, 2026 07:30 ET | Source: ZenaTech Inc.

ZenaTech Completes 20th Acquisition in Year One of Drone as a Service, Strengthening California Wildfire Management and Public Works Opportunities

Announces 20th Acquisition
January 08, 2026 07:30 ET | Source: Vera Therapeutics

Vera Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Vera Therapeutics to participate in the 44th Annual J.P. Morgan Healthcare Conference
January 08, 2026 07:30 ET | Source: Electra Battery Materials Corporation

Electra Provides Update on Refinery Project Progress

TORONTO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”), a leader in advancing North America’s critical minerals...
January 08, 2026 07:30 ET | Source: Zevra Therapeutics

Zevra Therapeutics to Present at the J.P. Morgan 44th Annual Healthcare Conference

CELEBRATION, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living...
January 08, 2026 07:30 ET | Source: Dragonfly Energy Holdings Corp.

Dragonfly Energy Issues Year-End CEO Letter to Shareholders

RENO, Nev., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage, today issued a Year-End...
January 08, 2026 07:30 ET | Source: Beneficient

Beneficient Enters into $3 Million GP Primary Capital Transaction

Beneficient (Nasdaq: BENF) announced it has closed on the financing of an approximately $3 million primary capital commitment for Cork & Vines Fund I, LP.